The use of Yttrium-90 Ibritumomab Tiuxetan ( 90 Y-IT) as a consolidation therapy in high-risk patients with diffuse large B-cell lymphoma ineligible for autologous stem-cell transplantation
Abstract
Citations
-
0
CrossRef
-
0
Web of Science
-
4
Scopus
Authors (6)
Cite as
Full text
full text is not available in portal
Details
- Category:
- Magazine publication
- Type:
- Magazine publication
- Published in:
-
Wspolczesna Onkologia-Contemporary Oncology
no. 1,
pages 43 - 47,
ISSN: 1428-2526 - ISSN:
- 1428-2526
- Publication year:
- 2015
- DOI:
- Digital Object Identifier (open in new tab) 10.5114/wo.2015.50012
- Verified by:
- No verification
seen 44 times